Butrans Related Clinical Trials
Butrans for Treatment of Restless Legs Syndrome [Withdrawn]
Buprenorphine for the Treatment of Neonatal Abstinence Syndrome [Completed]
Preference for Subutex� (Buprenorphine) Versus Suboxone� (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex� (Study P05094)(COMPLETED) [Completed]
A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction [Completed]
Disposition Effects of Cyclosporin on Buprenorphine [Recruiting]
Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects [Completed]
Buprenorphine Used With Treatment Resistant Depression in Older Adults [Not yet recruiting]
Buprenorphine Group Medical Visits in Primary Care [Not yet recruiting]
Integrating Buprenorphine Into the SFGH AIDS Program [Completed]
Buprenorphine Treatment for Opioid Dependence [Recruiting]
Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole [Completed]
Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine [Recruiting]
Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain [Completed]
Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain [Terminated]
Multiple Dose Study of Blockade of Opioid Effects of Injections of Buprenorphine in Participants With Opioid Disorder [Completed]
Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS) [Enrolling by invitation]
Study Assessing the Safety and Therapeutic Effect of Buprenorphine in MDD Patients [Not yet recruiting]
Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone [Completed]
An Open Label Study To Assess The Safety And Tolerability Of BEMA� Buprenorphine NX In Opioid Dependent Subjects [Completed]
Study of Two Formulations of Buprenorphine HCl in Opioid-dependent Subjects on Buprenorphine Maintenance Therapy (Study P04451) (COMPLETED) [Completed]
A Study to Evaluate the Pharmacokinetic Effect of SCH 503034 (Boceprevir) on Methadone or Buprenorphine/Naloxone Plasma Concentrations (P08123) [Completed]
Buprenorphine for Treatment Resistant Depression [Completed]
Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence [Completed]
The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects [Not yet recruiting]
Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions [Completed]
Fetal and Infant Effects of Maternal Buprenorphine Treatment [Recruiting]
Observational Study of Misuse of High Dose Buprenorphine (Subutex� or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED) [Completed]
Study of Probuphine in Patients With Opioid Dependence [Terminated]
Re-Treatment Study of Probuphine in Opioid Addiction [Completed]
Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine [Recruiting]
Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome [Recruiting]
Buprenorphine in the Treatment of Osteoarthritis (OA) in the Elderly [Completed]
Improved Strategies for Outpatient Opioid Detoxification [Recruiting]
The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (Mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers [Completed]
Cocaine Use Reduction With Buprenorphine [Completed]
Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients [Completed]
Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepines [Recruiting]
Effects of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sublingual and Intravenous Buprenorphine [Completed]
Drug Interaction & Methadone & Buprenorphine [Completed]
Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain - a 28-week Extension Study [Completed]
Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir) [Completed]
Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients [Recruiting]
Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches [Recruiting]
HIV Risk Reduction in Subutex Injectors in Tbilisi [Active, not recruiting]
Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444) [Completed]
Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015 [Terminated]
Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension. [Terminated]
Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME") [Completed]
The Effects of Buprenorphine on Responses to Verbal Tasks [Recruiting]
Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase. [Terminated]
Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Osteoarthritis Pain [Terminated]
Pilot Test of a Community-based Buprenorphine Treatment Intervention [Completed]
A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence [Terminated]
Buprenorphine for Late-Life Treatment Resistant Depression [Completed]
Pharmacokinetics, Safety, and Efficacy of Intravenous Dosing of Buprenorphine in Pediatric Patients Who Require Opioid Analgesia for Acute Moderate to Severe Pain [Withdrawn]
Pupillometry and Pain Thresholds Patients Substituted by Methadone and Buprenorphine [Recruiting]
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children [Recruiting]
Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM) [Completed]
The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) on QT Intervals in Healthy Volunteers [Completed]
The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain. [Completed]
Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications [Completed]
Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee [Completed]
Postoperative Analgesia With Buprenorphine for Postoperative Pain Control and Quality of Life After Spinal Surgery [Recruiting]
Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase [Terminated]
Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment [Recruiting]
Study of the Treatment of Experimental Pain in Buprenorphine Maintained Persons With Chronic Musculoskeletal Pain [Recruiting]
Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance [Recruiting]
A Study of Breastfeeding in Buprenorphine Maintained Women [Enrolling by invitation]
Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals [Completed]
Drug-Drug Interaction Study Between Telaprevir and Buprenorphine [Completed]
Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence [Completed]
Prospective Cohort of Opiate Dependent Patients on Buprenorphine/Naloxone for Maintenance [Completed]
Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone [Completed]
Efficacy and Safety Study of BEMA Buprenorphine in Subjects With Low Back Pain [Completed]
A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED) [Completed]
Duration of Analgesia After Popliteal Fossa Nerve Blockade: Effects of Dexamethasone and Buprenorphine [Completed]
Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence [Completed]
Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/Naloxone [Completed]
Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity [Completed]
Prison Buprenorphine [Completed]
Efficacy of Buprenorphine for Treatment of Acute Pain [Completed]
An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders [Active, not recruiting]
Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents [Withdrawn]
Randomized, Double-Blind Cross-Over Trial Of Buprenorphine and Low-Dose Naloxone Versus Buprenorphine [Completed]
Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir [Completed]
Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone [Recruiting]
Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population [Active, not recruiting]
A Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine® Subdermal Implants [Active, not recruiting]
Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants [Completed]
Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults [Completed]
Safety and Tolerability of Buprenorphine/Naloxone Film Strips [Completed]
Examination of Cognitive Function in Patients Treated With Subutex [Completed]
Buprenorphine as a Treatment in Opiate Dependent Pain Patients [Terminated]
Sublingual Buprenorphine for Chronic Pain [Not yet recruiting]
Buprenorphine to Improve HIV Care Engagement and Outcomes (BRAVO) [Recruiting]
|
